This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
What were the billion-dollar large molecules in 2021? This article and infographic, which is part 4 of a Premium series…
Article
11 months ago ●
3 mins read
Context. AZD1390 (recently published on by University of Minnesota) is a brain-penetrating Ataxia-Telangiectasia Mutated (ATM) kinase inhibitor under development for…
molecule
5 months ago ●
4 mins read
This article and infographic highlights the drug discovery biotech acquisitions of 2021 where the upfront payment was disclosed, along with…
Article
12 months ago ●
3 mins read
Context. CH7057288 (Chugai Pharmaceutical Co) is an oral pan-tropomyosin receptor kinase (TRK) inhibitor. Chromosomal rearrangements in the NTRK1–3 genes that…
molecule
5 months ago ●
4 mins read
We reviewed all of the biotech mergers and acquisitions announced in 2021 and did a deep dive on the list…
Article
12 months ago ●
3 mins read
Context. Vadadustat (Akebia Therapeutics) is an oral hypoxia-inducible factor prolyl-4-hydroxylase domain (HIF-PHD) inhibitor being developed for anemia in patients with…
molecule
5 months ago ●
4 mins read
Load More
